Hopital Larchet 2 Chu Nice

Nice 06200

0 studies enrolling now · 2 studies all time

What they study most

Advanced Malignancies, Marginal Zone Lymphoma, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Study of Tislelizumab, Pamiparib, and Other Investigational Agents in Participants With Advanced Malignancies — Completed